Impact of Inhaled and Intranasal Corticosteroids Exposure on the Risk of Ocular Hypertension and Glaucoma: A Systematic Review and Meta-Analysis

A Vinokurtseva, M Fung, E Ai Li, R Zhang… - Clinical …, 2022 - Taylor & Francis
Purpose Starting in 2019, the Global Initiative for Asthma recommended the use of inhaled
corticosteroids (ICS) as part of reliever combination therapy in patients 12 years of age and …
被引用次数：4 相关文章

Impact of Inhaled and Intranasal Corticosteroids Exposure on the Risk of Ocular Hypertension and Glaucoma: A Systematic Review and Meta-Analysis

A Vinokurtseva, M Fung, EA Li, R Zhang… - Clinical …, 2022 - dovepress.com
Purpose: Starting in 2019, the Global Initiative for Asthma recommended the use of inhaled
corticosteroids (ICS) as part of reliever combination therapy in patients 12 years of age and …

Impact of Inhaled and Intranasal Corticosteroids Exposure on the Risk of Ocular Hypertension and Glaucoma: A Systematic Review and Meta-Analysis

A Vinokurtseva, M Fung, EA Li… - Clinical …, 2022 - pubmed.ncbi.nlm.nih.gov
Purpose Starting in 2019, the Global Initiative for Asthma recommended the use of inhaled
corticosteroids (ICS) as part of reliever combination therapy in patients 12 years of age and …
[HTML] nih.gov

[HTML][HTML] Impact of Inhaled and Intranasal Corticosteroids Exposure on the Risk of Ocular Hypertension and Glaucoma: A Systematic Review and Meta-Analysis

A Vinokurtseva, M Fung, EA Li, R Zhang… - Clinical …, 2022 - ncbi.nlm.nih.gov
Purpose Starting in 2019, the Global Initiative for Asthma recommended the use of inhaled
corticosteroids (ICS) as part of reliever combination therapy in patients 12 years of age and …

Impact of Inhaled and Intranasal Corticosteroids Exposure on the Risk of Ocular Hypertension and Glaucoma: A Systematic Review and Meta-Analysis.

A Vinokurtseva, M Fung, A Li, R Zhang… - Clinical …, 2022 - europepmc.org
Purpose Starting in 2019, the Global Initiative for Asthma recommended the use of inhaled
corticosteroids (ICS) as part of reliever combination therapy in patients 12 years of age and …